Erdolyt 300 mg Capsule

Erdolyt 300 mg Capsule Uses, Dosage, Side Effects, Food Interaction and all others data.

Erdolyt 300 mg Capsule is a prodrug that is metabolised into N-thiodiglycolyl-homocysteine whereby free thiol groups are formed leading to the opening of the disulphide bonds of the bronchial mucoproteins, thus reducing the viscosity of mucus and purulent sputum. It also antagonises the local formation of free radicals and inhibits elastase enzyme activity and bacterial adhesion to epithelial cells.

Trade Name Erdolyt 300 mg Capsule
Generic Erdosteine
Erdosteine Other Names Erdosteine
Weight 300 mg
Type Capsule
Formula C8H11NO4S2
Weight Average: 249.307
Monoisotopic: 249.012949225
Groups Approved, Investigational
Therapeutic Class Cough expectorants & mucolytics
Manufacturer Ziska Pharmaceuticals Ltd.
Available Country Bangladesh
Last Updated: September 24, 2024 at 5:38 am
Erdolyt 300 mg Capsule
Erdolyt 300 mg Capsule

Uses

Erdolyt 300 mg Capsule is a mucolytic drug used in the treatment of acute and chronic respiratory diseases. It also improves the symptoms associated with short episodes of chronic bronchitis.

Erdolyt 300 mg Capsule is also used to associated treatment for these conditions: Excess mucus or phlegm, Airway secretion clearance therapy

How Erdolyt 300 mg Capsule works

Erdolyt 300 mg Capsule, is an orally administered mucolytic agent. It is classified as a thiol derivative and produced for the management of symptoms caused by chronic obstructive bronchitis. Erdolyt 300 mg Capsule contains sulfhydryl groups which are released after hepatic first-pass metabolism in the liver. Its active metabolites (3 in number) exert both mucolytic activity and scavenging activity against free radicals. Erdolyt 300 mg Capsule acts to regulate the production of mucus in the airway and regulates its viscosity while enhancing mucociliary transport. This leads to an increase in expectoration. Erdolyt 300 mg Capsule shows inhibition against the effects of free radicals from cigarette smoke. Clinical studies in patients with chronic obstructive lung disease (COPD) have shown that this drug is generally safe and well tolerated. Erdolyt 300 mg Capsule 300mg twice daily reduced cough (both frequency and severity) and sputum viscosity more quickly and more effectively than placebo and reduced the adhesivity of sputum more effectively than ambroxol 30mg twice daily. Co-administration of erdosteine and amoxicillin in patients with acute infective exacerbation of chronic bronchitis resulted in higher concentrations of the antibiotic in the sputum, leading to earlier and more pronounced amelioration of clinical symptoms compared with placebo. Erdolyt 300 mg Capsule is associated with a low incidence of adverse events, most of which are gastrointestinal and generally mild.

Dosage

Erdolyt 300 mg Capsule dosage

The usual dose of elderly patients and adults above 18 years is 1 capsule twice daily for 10 days. But study shows that in chronic cases Erdolyt 300 mg Capsule can be given up to 12 months or as directed by the physician. Erdolyt 300 mg Capsule capsule may be taken with or without food.

Side Effects

Common side effect is epigastric pain. Other side effects include headache, cold, taste alterations, nausea, vomiting, diarrhea, angioedema and other skin allergic reactions.

Precaution

It should be used with caution in mild liver failure. In that case, should not exceed a dose of 300 mg per day.

Pregnancy & Breastfeeding use

The use of Erdolyt 300 mg Capsule in pregnant or breast-feeding women is not recommended.

Contraindication

It is contraindicated to patients who have hypersensitivity to Erdolyt 300 mg Capsule. It should not be used in patients with creatinine clearance <25 ml/min, or with severe liver failure.

Special Warning

Renal Impairment: CrCl <25 ml/min: Contraindicated.

Hepatic Impairment:

  • Mild to moderate: Max: 300 mg daily.
  • Severe: Contraindicated.

Storage Condition

Keep in a dry place away from light and heat. Keep out of reach of children

Innovators Monograph

You find simplified version here Erdolyt 300 mg Capsule

Erdolyt 300 mg Capsule contains Erdosteine see full prescribing information from innovator Erdolyt 300 mg Capsule Monograph, Erdolyt 300 mg Capsule MSDS, Erdolyt 300 mg Capsule FDA label

*** Taking medicines without doctor's advice can cause long-term problems.
Share